Dr. Raja Elina, the President of the Malaysian Association of Clinical Biochemists (MACB), spoke at Smart Partnership for Early Actions in Chronic Kidney Disease event about the management of Chronic Kidney Disease (CKD) in Malaysia. She emphasized the importance of early detection, treatment, and management of CKD.

To improve these aspects, AstraZeneca has entered into a partnership with several organizations including the Malaysian Society of Nephrology (MSN), the MACB, Chapter of Chemical Pathology and Metabolic Medicine, College of Pathologists, Academy of Medicine of Malaysia (CPMM, CPath AMM), Premier Integrated Labs, Innoquest Pathology, Lablink Medical Laboratory, and Sunway Medical Centre Laboratory.

The partnership aims to harness advanced digital solutions such as the MyCKD CPG app and the Kidney Failure Risk Equation (KFRE) in CKD management. These initiatives are expected to significantly enhance the health literacy in Malaysia, particularly in the area of CKD.

For more information, you can read more on the provided links. 

https://codeblue.galencentre.org/2024/05/08/new-chronic-kidney-disease-app-predictive-kidney-failure-tool-launched/
https://www.kosmo.com.my/2024/05/07/astrazeneca-lancar-myckd-cpg-intervensi-penyakit-buah-pinggang-kronik/

https://thesun.my/style-life/advancing-early-actions-in-chronic-kidney-disease-PD12442814

https://www.malaysiakini.com/announcement/704971